ClassID:

2184

A01K2217/058 - CPC Classification

Classification description:

Genetically modified animals; Animals comprising random inserted nucleic acids (transgenic) inducing loss of function due to expression of inhibitory nucleic acid, e.g. siRNA, antisense

Recent Application in this class:
#1
20260033466
2026-02-05

METHOD AND ANIMAL MODEL FOR INDUCING BCC TUMORS

#2
20250320527
2025-10-16

DNA EDITING USING SINGLE-STRANDED DNA

#3
20250248379
2025-08-07

piRNA-BASED CONSTRUCTS FOR REGULATING GENE EXPRESSION AND METHODS OF USE THEREOF

#4
20250160307
2025-05-22

BRAIN TUMOR MODEL

#5
20250151705
2025-05-15

PROCESS OF TRANSFECTING PRIMORDIAL GERM CELLS IN AN AVIAN

#6
20250143271
2025-05-08

METHOD FOR PRODUCING STERILIZED MALE INDIVIDUALS OF MARINE FISH, METHOD FOR PREVENTING REPRODUCTION OF MARINE FISH, AND STERILIZED MALE INDIVIDUALS OF MARINE FISH

#7
20250101454
2025-03-27

COMPOSITION FOR TREATMENT OF SEPSIS BY REGULATING OLFR164

#8
20240373830
2024-11-14

METHODS OF MODULATING SEX RATIO

#9
20240358007
2024-10-31

High Efficiency Beef Cattle Having Modified ACTN3 Genes

#10
20230340541
2023-10-26

DNA EDITING USING SINGLE-STRANDED DNA

#11
20230189769
2023-06-22

Process for using CRISPR to transfect primordial germ cells in avians

#12
20230078551
2023-03-16

Non-human animals comprising a humanized TTR locus and methods of use

#13
20230003717
2023-01-05

USE OF SYNAPTOTAGMIN-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER

#14
20220322647
2022-10-13

A METHOD OF GENERATING STERILE PROGENY

#15
20220119818
2022-04-21

MYOSTATIN SIGNAL INHIBITOR

#16
20210205476
2021-07-08

Isolation of novel AAV's and uses thereof

#17
20210185991
2021-06-24

ANIMAL MODEL FOR HEPATOCELLULAR CARCINOMA AND USES THEREOF

#18
20210112789
2021-04-22

Process of transfecting primordial germ cells in an avian

#19
20200399661
2020-12-24

MATERIALS AND METHODS FOR PREVENTING TRANSMISSION OF A PARTICULAR CHROMOSOME

#20
20190300901
2019-10-03

MATERIALS AND METHODS FOR MAKING A RECESSIVE GENE DOMINANT

#21
20190297860
2019-10-03

Repressors of viral infection

#22
20190289835
2019-09-26

Mouse Models Having a Knockin Scavenger Receptor Class B Type I

#23
20190282709
2019-09-19

Isolation of novel AAV's and uses thereof

#24
20190261609
2019-08-29

Process for using crispr to transfect primordial germ cells in avians

#25
20190098879
2019-04-04

Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use

#26
20180355352
2018-12-13

INHIBITING GENE EXPRESSION WITH dsRNA

#27
20180334675
2018-11-22

Culicinae Mosquito TRA-2 RNA Interference Technique to Genetically Produce Maleness Population

#28
20180263226
2018-09-20

COMPOSITIONS AND METHODS FOR CREATING PANCREATIC CANCER ANIMAL MODEL

#29
20180258399
2018-09-13

Method of making trabecular bone

#30
20180187215
2018-07-05

DNA editing using relatively long single-stranded DNA and CRISPR/Cas9 to increase success rate in methods for preparing transgenic embryos and animals

#31
20180127787
2018-05-10

Treatment methods using DNA editing with single-stranded DNA

#32
20180105835
2018-04-19

Targeted RNA knockdown and knockout by type III-A Csm complexes

#33
20180030546
2018-02-01

Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors

#34
20170166927
2017-06-15

Isolation of novel AAV's and uses thereof

#35
20170165377
2017-06-15

Isolation of novel AAV's and uses thereof

#36
20170096667
2017-04-06

INHIBITING GENE EXPRESSION WITH dsRNA

#37
20170049083
2017-02-23

Mouse λ light chain locus

#38
20170014441
2017-01-19

Induction of thyroid iodide-handling gene expression in human cancers

#39
20160368954
2016-12-22

Methods for treating disorders that involve immunoglobulin A

#40
20160135438
2016-05-19

Isolation of novel AAV's and uses thereof

#41
20150329913
2015-11-19

Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors

#42
20150273081
2015-10-01

Reversibly masked polymers

#43
20150072064
2015-03-12

Method of making a chicken with germ cells expressing marker protein

#44
20140331342
2014-11-06

Culicinae mosquito Tra-2 RNA interference technique to genetically produce maleness population

#45
20140301943
2014-10-09

Induction of thyroid iodide-handling gene expression in human cancers

#46
20140227266
2014-08-14

Nogo receptor antagonists and methods of increasing neurite outgrowth

#47
20140051745
2014-02-20

Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair

#48
20130298269
2013-11-07

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#49
20130149309
2013-06-13

Regulatory proteins and inhibitors

#50
20130067606
2013-03-14

MODULATING PRODUCTION TRAITS IN AVIANS

#51
20130046079
2013-02-21

Mouse λ light chain locus

#52
20130024961
2013-01-24

Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs

#53
20120230938
2012-09-13

Polyconjugates for in vivo delivery of polynucleotides

#54
20120167242
2012-06-28

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#55
20120084873
2012-04-05

SEX-DETERMINATION AND METHODS OF SPECIFYING SAME

#56
20120073005
2012-03-22

TRANSGENIC ANIMAL CARRYING AT LEAST TWO TYPES OF FOREIGN FUNCTIONAL RNA

#57
20120047589
2012-02-23

METHOD OF DELIVERY OF NUCLEIC ACIDS TO A DEVELOPING EMBRYO

#58
20120030782
2012-02-02

Compositions and Methods for Generating Transgenic Animals

#59
20120005765
2012-01-05

ANIMAL MODEL FOR PARKINSON'S DISEASE

#60
20110230543
2011-09-22

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

#61
20110209231
2011-08-25

TREATMENT AND PREVENTION OF INFLUENZA

#62
20110117102
2011-05-19

Therapeutic uses of inhibitors of RTP801

#63
20110093961
2011-04-21

Mouse λ light chain locus

#64
20110078805
2011-03-31

COMPOSITIONS AND METHODS FOR GENERATING TRANSGENIC ANIMALS

#65
20110076681
2011-03-31

Modified gene-silencing nucleic acid molecules and uses thereof

#66
20110055941
2011-03-03

Chd5 is a novel tumor suppressor gene

#67
20110038792
2011-02-17

Induction of thyroid iodide-handling gene expression in human cancers

#68
20110034533
2011-02-10

Compositions and methods modulating MG29 for the treatment of diabetes

#69
20110028532
2011-02-03

Methods of treating eye diseases in diabetic patients

#70
20110010784
2011-01-13

Insulin-like gene of prawns and uses thereof

#71
20100319073
2010-12-16

GDE Compositions and Methods

#72
20100317713
2010-12-16

Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

#73
20100306869
2010-12-02

MODULATING PRODUCTION TRAITS IN AVIANS

#74
20100273660
2010-10-28

ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS

#75
20100272813
2010-10-28

NANOPARTICLE-MEDIATED TREATMENT FOR INFLAMMATORY DISEASES

#76
20100233135
2010-09-16

COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL EXPANSION OR FOR MODULATING ANGIOGENESIS

#77
20100227907
2010-09-09

Method of Treating Pain by Using Opioids and CAMKIV Inhibitors

#78
20100186103
2010-07-22

Isolation of novel AAV'S and uses thereof

#79
20100172976
2010-07-08

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

#80
20100169995
2010-07-01

TARGETED GENE DISRUPTIONS IN THE IQGAP2 GENE

#81
20100150839
2010-06-17

Compositions and Methods for Modulating Cognitive Function

#82
20100146655
2010-06-10

Method for producing a transgenic pig using a hyper-methylated transposon

#83
20100119454
2010-05-13

Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response

#84
20100100978
2010-04-22

RNAi mediated expression inhibition of a cholinergic protein

#85
20100029747
2010-02-04

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

#86
20100017901
2010-01-21

Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use

#87
20100005535
2010-01-07

Compositions And Methods For Generating Transgenic Animals

#88
20090313712
2009-12-17

RNA interference and disease resistance in avians

#89
20090265795
2009-10-22

Methods of inhibiting multiple cytochrome P450 genes with siRNA

#90
20090263364
2009-10-22

Method and constructs for delivering double stranded RNA to pest organisms

#91
20090235373
2009-09-17

METHOD OF DELIVERY OF NUCLEIC ACIDS TO A DEVELOPING EMBRYO

#92
20090222934
2009-09-03

Transgenic mouse model of B cell malignancy

#93
20090215864
2009-08-27

Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer

#94
20090187997
2009-07-23

Cre-lox based gene knockdown constructs and methods of use thereof

#95
20090169523
2009-07-02

HSC SELF-RENEWAL

#96
20090099078
2009-04-16

Nogo receptor antagonists

#97
20090055940
2009-02-26

ZEBRAFISH MODEL OF MLL LEUKEMOGENESIS

#98
20090048410
2009-02-19

Membrane active heteropolymers

#99
20090031433
2009-01-29

METHODS FOR SCREENING INSECTICIDES

#100
20090029872
2009-01-29

Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof

#101
20090023890
2009-01-22

Membrane active heteropolymers

#102
20080313747
2008-12-18

Targeted Transgenesis of Short Hairpin Rna Expression Cassettes Using Recombinase Mediated Cassette Exchange

#103
20080292591
2008-11-27

Tumor mouse models using lentiviral vectors

#104
20080287630
2008-11-20

Endosomolytic poly(acrylate) polymers

#105
20080287628
2008-11-20

Endosomolytic poly(vinyl ether) polymers

#106
20080281074
2008-11-13

Compounds and methods for reversible modification of biologically active molecules

#107
20080281044
2008-11-13

Endosomolytic Modified Poly(Alcohol) and Poly(Amine) Polymers

#108
20080281041
2008-11-13

Reversibly Masked Polymers

#109
20080269450
2008-10-30

Endosomolytic Poly-Beta-Aminoester Polymers

#110
20080242628
2008-10-02

Inhibiting Gene Expression with dsRNA

#111
20080222743
2008-09-11

RNA interference and disease resistance in avians

#112
20080221054
2008-09-11

Inhibiting Gene Expression with dsRNA

#113
20080214666
2008-09-04

Products and Methods Related to Mono-Methyl Branched-Chain Fatty Acids

#114
20080194514
2008-08-14

Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences

#115
20080188434
2008-08-07

Role of FGF-20 in cancer diagnosis and treatment

#116
20080153764
2008-06-26

System and Methods For Short Rna Expression

#117
20080152661
2008-06-26

Polyconjugates for in vivo delivery of polynucleotides

#118
20080081792
2008-04-03

Methods and compositions for inhibiting the function of polynucleotide sequences

#119
20080064648
2008-03-13

Methods and Compositions Relating to Lipid Accumulation

#120
20080044906
2008-02-21

Modified Gene-Silencing Nucleic Acid Molecules and Uses Thereof

#121
20080039420
2008-02-14

Method for inhibiting NOX1 gene expression

#122
20070269378
2007-11-22

Nadks as Modifiers of Branching Morphogenesis and Methods of Use

#123
20070238178
2007-10-11

Methods and compositions for inhibiting the function of polynucleotide sequences

#124
20070232557
2007-10-04

Methods and compositions for inhibiting the function of polynucleotide sequences

#125
20070219151
2007-09-20

Methods and compositions for inhibiting the function of polynucleotide sequences

#126
20070191295
2007-08-16

Gene silencing by systemic rna interference

#127
20070172486
2007-07-26

Expression of cyclin G1 in tumors

#128
20070136828
2007-06-14

Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders

#129
20070113295
2007-05-17

Gene blocking method

#130
20070111258
2007-05-17

Compositions and methods for modulating the acute phase response

#131
20070110728
2007-05-17

Method for preventing and treating diabetes using dg119

#132
20070093438
2007-04-26

Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases

#133
20070022482
2007-01-25

High-throughput functional analysis of gene expression

#134
20060246432
2006-11-02

Methods and materials for modulating task-3

#135
20060228707
2006-10-12

Eukaryotic genes involved in adult lifespan regulation

#136
20060218654
2006-09-28

Sirna mediated gene silencing in transgenic animals

#137
20060217329
2006-09-28

Therapeutic uses of inhibitors of RTP801

#138
20060156421
2006-07-13

High throughput screening methods for anti-metastatic compounds

#139
20060104956
2006-05-18

Methods and compositions for inhibiting the function of polynucleotide sequences

#140
20060031949
2006-02-09

Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals

#141
20060031948
2006-02-09

Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals

#142
20060031945
2006-02-09

Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals

#143
20060010505
2006-01-12

High throughput cancer pharmaceutical screening using drosophila

#144
20050283845
2005-12-22

Method for producing non-human mammal having RNAi phenotype

#145
20050266561
2005-12-01

Use of interfering RNA in the production of transgenic animals

#146
20050251872
2005-11-10

Lentiviral vectors, related reagents, and methods of use thereof

#147
20050239202
2005-10-27

Methods and compositions for inhibiting the function of polynucleotide sequences

#148
20050229272
2005-10-13

Compositions and methods for gene silencing

#149
20050210536
2005-09-22

Modulation of brain pathways and function

#150
20050142568
2005-06-30

Cell death-related nucleases and their uses

#151
20050130919
2005-06-16

Regulatable promoters for synthesis of small hairpin RNA

#152
20050095240
2005-05-05

NaCT as a target for lifespan expansion and weight reduction

#153
20050071893
2005-03-31

SiRNA mediated gene silencing in transgenic animals

#154
20050060763
2005-03-17

Mouse λ light chain locus